Vaccine sales declined..Pfizer reduces its profits. Here are the details
2023-10-15 05:02:12 Pfizer cut its full-year earnings and revenue guidance last Friday, citing demand for its Covid products as waning. The company now expects sales of $58 to $61 billion in 2023, down from its previous forecast of $67 to $70 billion. Pfizer said it lowered its revenue forecast “due solely to COVID-19 products.” The … Read more